---
document_datetime: 2025-12-29 11:48:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/clopidogrel-acetylsalicylic-acid-zentiva.html
document_name: clopidogrel-acetylsalicylic-acid-zentiva.html
version: success
processing_time: 0.1103018
conversion_datetime: 2025-12-31 02:47:38.691668
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover)

[RSS](/en/individual-human-medicine.xml/66917)

##### Authorised

This medicine is authorised for use in the European Union

clopidogrel / acetylsalicylic acid Medicine Human Authorised

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

This document is a summary of the European Public Assessment Report (EPAR) for Clopidogrel/Acetylsalicylic acid Zentiva. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Clopidogrel/Acetylsalicylic acid Zentiva.

Expand section

Collapse section

## What is Clopidogrel/Acetylsalicylic acid Zentiva?

Clopidogrel/Acetylsalicylic acid Zentiva is a medicine that contains two active substances, clopidogrel and acetylsalicylic acid (also known as aspirin). It is available as tablets containing 75 mg clopidogrel, either with 75 mg or 100 mg acetylsalicylic acid.

## What is Clopidogrel/Acetylsalicylic acid Zentiva used for?

Clopidogrel/Acetylsalicylic acid Zentiva is used to prevent problems caused by blood clots, such as a heart attack, in adults who are already taking both clopidogrel and acetylsalicylic acid as separate tablets. It can be used in the following groups of patients who have a condition known as 'acute coronary syndrome':

- patients who have unstable angina (a severe type of chest pain) or who have had a heart attack with no 'ST-segment elevation' (an abnormal reading on the ECG or electrocardiogram), including those who are having a stent (a short tube) inserted into an artery to prevent it from closing up;
- patients being treated for heart attack with ST-segment elevation, when the doctor thinks that they would benefit from treatment to dissolve blood clots.

The medicine can only be obtained with a prescription.

## How is Clopidogrel/Acetylsalicylic acid Zentiva used?

Clopidogrel/Acetylsalicylic acid Zentiva is taken as one tablet once a day in place of the clopidogrel and acetylsalicylic acid tablets that the patient has already been taking separately.

## How does Clopidogrel/Acetylsalicylic acid Zentiva work?

Both active substances in Clopidogrel/Acetylsalicylic acid Zentiva, clopidogrel and acetylsalicylic acid, are antiplatelet medicines. This means that they help to prevent blood cells called platelets from sticking together and forming clots, thus helping to prevent another heart attack.

Clopidogrel stops the platelets sticking together by blocking a substance called ADP from attaching to a special receptor on their surface. This stops the platelets becoming 'sticky', reducing the risk of a blood clot forming. Acetylsalicylic acid stops the platelets sticking together by blocking an enzyme called prostaglandin cyclo-oxygenase. This reduces the production of a substance called thromboxane, which normally helps clots to form by attaching platelets together. The combination of the two active substances has an additive effect, reducing the risk of blood clots forming more than either medicine alone.

Both active substances have been available in the European Union (EU) for a number of years. Clopidogrel has been authorised since 1998 for reducing platelet aggregation, and is often used in combination with acetylsalicylic acid. Acetylsalicylic acid has been available for over 100 years.

## How has Clopidogrel/Acetylsalicylic acid Zentiva been studied?

Because the two active substances have been used together for a number of years, the company presented the results of studies showing that the active substances in Clopidogrel/Acetylsalicylic acid Zentiva are absorbed in the body in the same way when taken in a single tablet as when the two medicines are taken separately. It also presented the results of 3 previous studies involving over 61,000 patients with unstable angina or who had had a heart attack.

## What benefit has Clopidogrel/Acetylsalicylic acid Zentiva shown during the studies?

Clopidogrel/Acetylsalicylic acid Zentiva was shown to be comparable to clopidogrel and acetylsalicylic acid taken separately, and can therefore be used in place of the clopidogrel and acetylsalicylic acid tablets that the patients have already been taking.

Results from the 3 studies in patients with unstable angina or who had had a heart attack showed that the combination of clopidogrel and acetylsalicylic acid taken as separate tablets was more effective at preventing events such as heart attacks than acetylsalicylic acid alone.

## What is the risk associated with Clopidogrel/Acetylsalicylic acid Zentiva?

The most common side effects with Clopidogrel/Acetylsalicylic acid Zentiva (seen in between 1 and 10 patients in 100) are haematoma (a collection of blood under the skin), epistaxis (nosebleeds), gastrointestinal haemorrhage (bleeding in the stomach or gut), diarrhoea, abdominal pain (stomach ache), dyspepsia (heartburn), bruising, and bleeding where the skin is punctured. For the full list of all side effects reported with Clopidogrel/Acetylsalicylic acid Zentiva, see the package leaflet.

Clopidogrel/Acetylsalicylic acid Zentiva must not be used in people who are hypersensitive (allergic) to clopidogrel, non steroidal anti-inflammatory drugs (such as acetylsalicylic acid) or any of the other ingredients in Clopidogrel/Acetylsalicylic acid Zentiva. It must not be used in patients who have a disease that is causing bleeding, such as stomach ulcer or bleeding in the brain, or in patients with mastocytosis (high blood levels of certain white blood cells called mast cells). It must not be used in patients who have severely reduced liver or kidney function, or who have a medical condition that includes a combination of asthma, rhinitis (stuffy and runny nose) and nasal polyps (growths in the lining of the nose). Clopidogrel/Acetylsalicylic acid Zentiva must not be used during the last three months of pregnancy.

## Why has Clopidogrel/Acetylsalicylic acid Zentiva been approved?

The CHMP noted that Clopidogrel/Acetylsalicylic acid Zentiva is comparable to clopidogrel and acetylsalicylic acid tablets taken separately, and concluded that combining both active substances in a single Clopidogrel/Acetylsalicylic acid Zentiva tablet simplifies treatment for patients as they will need to take fewer tablets. The Committee therefore decided that Clopidogrel/Acetylsalicylic acid Zentiva's benefits are greater than its risks and recommended that it be given marketing authorisation.

## Other information about Clopidogrel/Acetylsalicylic acid Zentiva:

The European Commission granted a marketing authorisation valid throughout the EU for DuoCover on 15 March 2010. The name of the medicine was changed to Clopidogrel/Acetylsalicylic acid Zentiva on 15 January 2016.

For more information about treatment with Clopidogrel/Acetylsalicylic acid Zentiva, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.

Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) : EPAR - Summary for the public

English (EN) (91.02 KB - PDF)

**First published:** 31/03/2010

**Last updated:** 14/04/2016

[View](/en/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-25)

български (BG) (122.16 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/bg/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_bg.pdf)

español (ES) (91.37 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/es/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_es.pdf)

čeština (CS) (119.37 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/cs/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_cs.pdf)

dansk (DA) (90.4 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/da/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_da.pdf)

Deutsch (DE) (92.68 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/de/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_de.pdf)

eesti keel (ET) (91.37 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/et/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_et.pdf)

ελληνικά (EL) (124.58 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/el/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_el.pdf)

français (FR) (92.29 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/fr/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_fr.pdf)

hrvatski (HR) (107.09 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/hr/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_hr.pdf)

italiano (IT) (90.42 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/it/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_it.pdf)

latviešu valoda (LV) (113.41 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/lv/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (104.87 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/lt/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_lt.pdf)

magyar (HU) (101.22 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/hu/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_hu.pdf)

Malti (MT) (109.12 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/mt/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_mt.pdf)

Nederlands (NL) (91.12 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/nl/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_nl.pdf)

polski (PL) (119 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/pl/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_pl.pdf)

português (PT) (90.97 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/pt/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_pt.pdf)

română (RO) (114.41 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/ro/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_ro.pdf)

slovenčina (SK) (117.75 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/sk/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_sk.pdf)

slovenščina (SL) (107.39 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/sl/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_sl.pdf)

Suomi (FI) (90.1 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/fi/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_fi.pdf)

svenska (SV) (90.6 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/sv/documents/overview/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-summary-public_sv.pdf)

## Product information

Clopidogrel/Acetylsalicylic acid Zentiva : EPAR - Product Information

English (EN) (317.49 KB - PDF)

**First published:** 31/03/2010

**Last updated:** 13/11/2019

[View](/en/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-827)

български (BG) (579.79 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/bg/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_bg.pdf)

español (ES) (219.64 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/es/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_es.pdf)

čeština (CS) (425 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/cs/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_cs.pdf)

dansk (DA) (319.87 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/da/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_da.pdf)

Deutsch (DE) (282.11 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/de/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_de.pdf)

eesti keel (ET) (542.52 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/et/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_et.pdf)

ελληνικά (EL) (478.38 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/el/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_el.pdf)

français (FR) (608.7 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/fr/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_fr.pdf)

hrvatski (HR) (600.69 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/hr/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_hr.pdf)

íslenska (IS) (685.36 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/is/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_is.pdf)

italiano (IT) (173.8 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/it/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_it.pdf)

latviešu valoda (LV) (473.39 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/lv/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_lv.pdf)

lietuvių kalba (LT) (361.54 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/lt/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_lt.pdf)

magyar (HU) (350.99 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/hu/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_hu.pdf)

Malti (MT) (589.34 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/mt/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_mt.pdf)

Nederlands (NL) (353.56 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/nl/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_nl.pdf)

norsk (NO) (527.28 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/no/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_no.pdf)

polski (PL) (673.31 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/pl/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_pl.pdf)

português (PT) (188.16 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/pt/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_pt.pdf)

română (RO) (411.69 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/ro/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_ro.pdf)

slovenčina (SK) (504.05 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/sk/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_sk.pdf)

slovenščina (SL) (313.03 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/sl/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_sl.pdf)

Suomi (FI) (499.36 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/fi/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_fi.pdf)

svenska (SV) (425.4 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

13/11/2019

[View](/sv/documents/product-information/clopidogrel-acetylsalicylic-acid-zentiva-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** WS/1665 19/09/2019

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) : EPAR - All Authorised presentations

English (EN) (58.25 KB - PDF)

**First published:** 31/03/2010

**Last updated:** 14/04/2016

[View](/en/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-32)

български (BG) (58.35 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/bg/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_bg.pdf)

español (ES) (74.11 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/es/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_es.pdf)

čeština (CS) (31.06 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/cs/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (27.8 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/da/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (27.39 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/de/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (28.22 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/et/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (48.88 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/el/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_el.pdf)

français (FR) (31.81 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/fr/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (43.11 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/hr/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (28.27 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/is/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_is.pdf)

italiano (IT) (47.05 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/it/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (90.81 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/lv/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (51.18 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/lt/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (108.79 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/hu/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (107.11 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/mt/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (29.65 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/nl/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (75.39 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/no/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_no.pdf)

polski (PL) (40.71 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/pl/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_pl.pdf)

português (PT) (27.57 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/pt/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_pt.pdf)

română (RO) (54 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/ro/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (38.45 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/sk/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (82.16 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/sl/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (31.38 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/fi/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (32.16 KB - PDF)

**First published:**

31/03/2010

**Last updated:**

14/04/2016

[View](/sv/documents/all-authorised-presentations/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) Active substance

- clopidogrel
- acetylsalicylic acid

International non-proprietary name (INN) or common name

- clopidogrel
- acetylsalicylic acid

Therapeutic area (MeSH)

- Acute Coronary Syndrome
- Myocardial Infarction

Anatomical therapeutic chemical (ATC) code B01AC30

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

- Acute Coronary Syndrome
- Myocardial Infarction

## Authorisation details

EMA product number EMEA/H/C/001144 Marketing authorisation holder

Sanofi-Aventis Groupe

54 rue La Boétie

Marketing authorisation issued 14/03/2010 Revision 22

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (239.09 KB - PDF)

**First published:** 28/09/2010

**Last updated:** 13/11/2019

[View](/en/documents/procedural-steps-after/clopidogrelacetylsalicylic-acid-zentiva-previously-duocover-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

DuoCover : EPAR - Public assessment report

English (EN) (515.19 KB - PDF)

**First published:** 31/03/2010

**Last updated:** 31/03/2010

[View](/en/documents/assessment-report/duocover-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for DuoCover

Adopted

Reference Number: EMA/CHMP/765467/2009

English (EN) (34.44 KB - PDF)

**First published:** 17/12/2009

**Last updated:** 17/12/2009

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-duocover_en.pdf)

#### Topics

- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 13/11/2019

## Share this page

[Back to top](#main-content)